
Gliclazide (80mg) + Metformin (500mg)
Active composition
+1 more active ingredient
Gliclazide stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Glatix-M 80mg/500mg Tablet is a combination oral antidiabetic medication containing Gliclazide 80mg and Metformin 500mg, indicated for the management of type 2 diabetes mellitus. Gliclazide, a sulfonylurea class agent, stimulates pancreatic beta cells to enhance insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, primarily decreases hepatic glucose production and improves peripheral insulin sensitivity, contributing to better glycemic control. The synergistic action of these two agents helps achieve optimal blood sugar regulation in patients inadequately controlled by diet and exercise alone or monotherapy. Glatix-M is typically prescribed as part of a comprehensive diabetes management plan, including lifestyle modifications such as diet and physical activity. It is essential to monitor blood glucose levels regularly to adjust dosage and minimize the risk of hypoglycemia, a potential adverse effect associated with sulfonylureas. Metformin’s common side effects include gastrointestinal disturbances, which often subside with continued use. Caution is advised in patients with renal impairment, hepatic dysfunction, or cardiovascular conditions. Glatix-M should be used under medical supervision, with periodic assessment of renal function and glycemic status to ensure safety and efficacy.
How to use Glatix-M Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glatix-M 80mg/500mg Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Glatix-M 80mg/500mg Tablet.
High Risk
Glatix-M 80mg/500mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Glatix-M 80mg/500mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Glatix-M 80mg/500mg Tablet may be needed. Please consult your doctor. Glatix-M 80mg/500mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Glatix-M 80mg/500mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Glatix-M 80mg/500mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Glatix-M 80mg/500mg Tablet may be needed. Please consult your doctor. Use of Glatix-M 80mg/500mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Regular Checkup
0 reviews for Glatix-M 80mg/500mg Tablet

Gliclazide (80mg) + Metformin (500mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Gliclazide stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Glatix-M 80mg/500mg Tablet is a combination oral antidiabetic medication containing Gliclazide 80mg and Metformin 500mg, indicated for the management of type 2 diabetes mellitus. Gliclazide, a sulfonylurea class agent, stimulates pancreatic beta cells to enhance insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, primarily decreases hepatic glucose production and improves peripheral insulin sensitivity, contributing to better glycemic control. The synergistic action of these two agents helps achieve optimal blood sugar regulation in patients inadequately controlled by diet and exercise alone or monotherapy. Glatix-M is typically prescribed as part of a comprehensive diabetes management plan, including lifestyle modifications such as diet and physical activity. It is essential to monitor blood glucose levels regularly to adjust dosage and minimize the risk of hypoglycemia, a potential adverse effect associated with sulfonylureas. Metformin’s common side effects include gastrointestinal disturbances, which often subside with continued use. Caution is advised in patients with renal impairment, hepatic dysfunction, or cardiovascular conditions. Glatix-M should be used under medical supervision, with periodic assessment of renal function and glycemic status to ensure safety and efficacy.
How to use Glatix-M Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glatix-M 80mg/500mg Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Glatix-M 80mg/500mg Tablet.
High Risk
Glatix-M 80mg/500mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Glatix-M 80mg/500mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Glatix-M 80mg/500mg Tablet may be needed. Please consult your doctor. Glatix-M 80mg/500mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Glatix-M 80mg/500mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Glatix-M 80mg/500mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Glatix-M 80mg/500mg Tablet may be needed. Please consult your doctor. Use of Glatix-M 80mg/500mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Regular Checkup
0 reviews for Glatix-M 80mg/500mg Tablet













